KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Steris (STE) Net Income towards Common Stockholders (2017 - 2025)

Steris (STE) has 9 years of Net Income towards Common Stockholders data on record, last reported at -$783000.0 in Q1 2025.

  • For Q1 2025, Net Income towards Common Stockholders rose 99.49% year-over-year to -$783000.0; the TTM value through Dec 2025 reached -$783000.0, up 99.47%, while the annual FY2025 figure was $4.5 million, 102.61% up from the prior year.
  • Net Income towards Common Stockholders reached -$783000.0 in Q1 2025 per STE's latest filing, down from -$76000.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $143.1 million in Q4 2021 and bottomed at -$439.1 million in Q3 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$15.2 million, with a median of -$783000.0 recorded in 2025.
  • The widest YoY moves for Net Income towards Common Stockholders: up 182.46% in 2024, down 3338.22% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $143.1 million in 2021, then tumbled by 105.37% to -$7.7 million in 2022, then increased by 0.29% to -$7.7 million in 2023, then surged by 99.01% to -$76000.0 in 2024, then plummeted by 930.26% to -$783000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$783000.0 in Q1 2025, -$76000.0 in Q4 2024, and -$200000.0 in Q3 2024.